Diverse immunological dysregulation, chronic inflammation, and impaired erythropoiesis in long COVID patients with chronic fatigue syndrome

Authors: Saito, Suguru; Shahbaz, Shima; Osman, Mohammed; Redmond, Desiree; Bozorgmehr, Najmeh; Rosychuk, Rhonda J.; Lam, Grace; Sligl, Wendy; Cohen Tervaert, Jan Willem; Elahi, Shokrollah

Jul 2024

View article | Discussion on S4ME

Cohorts in this study

Phenotype: Long COVID

ARTN, CCL13, CCL2, CCL26, CD160, CD244, CD38, CD4, CD8A, CRP, CXCL10, ENTPD1, FABP2, HAVCR2, IL10, IL12B, IL16, IL1A, IL6, LGALS9, NT5E, PDCD1, PIGF, PTPRC, SAA1, TFRC, TGFB1, TIGIT, TNF, VCAM1, VEGFC

Phenotype: Long COVID, ME/CFS, Post-exertional malaise (PEM)

ARTN, CCL2, CCL22, CCL26, CCL3, CD160, CD244, CD38, CD4, CD8A, CRP, CXCL10, FABP2, HAVCR2, ICAM1, IFNG, IL12B, IL16, IL17A, IL1A, IL1B, IL6, LGALS9, NT5E, PDCD1, PIGF, PTPRC, SAA1, TFRC, TGFB1, TIGIT, TNF, VCAM1, VEGFC, VSIR

Notes

No notes yet.